Back to today’s briefing

Story perspectives

Breakthrough Gene Editing Enables Insulin Production in Diabetics

8/18/2025

42 8

Summary

Story summary

A 42-year-old type 1 diabetes patient produced insulin post-genetically edited pancreatic cell transplants, avoiding immunosuppressants.
Three successful CRISPR edits enabled the cells to withstand immune responses.
Researchers suggest this technique may improve diabetes treatments and be applicable to other transplant scenarios, as noted in The New England Journal of Medicine.

1 of 1

Story summary

A 42-year-old type 1 diabetes patient produced insulin post-genetically edited pancreatic cell transplants, avoiding immunosuppressants.
Three successful CRISPR edits enabled the cells to withstand immune responses.
Researchers suggest this technique may improve diabetes treatments and be applicable to other transplant scenarios, as noted in The New England Journal of Medicine.